Zydus Wellness Limited
National Stock Exchange of IndiaTotal Valuation
Zydus Wellness Limited carries a market capitalization of 35.63B, placing it among publicly traded companies globally. Its enterprise value stands at 128.79B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 35.63B |
| Enterprise Value | 128.79B |
Valuation Ratios
Zydus Wellness Limited trades at a trailing price-to-earnings ratio of 39.37.
| PE Ratio | 39.37 |
| PS Ratio | 4.75 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Zydus Wellness Limited trades at an EV/EBITDA multiple of 37.24 and an EV/FCF ratio of 1,273.34. The EV/Sales ratio of 4.75 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 37.24 provides insight into valuation relative to core operating earnings.
| EV / Sales | 4.75 |
| EV / EBITDA | 37.24 |
| EV / EBIT | 37.24 |
| EV / FCF | 1,273.34 |
Financial Position
Zydus Wellness Limited maintains a current ratio of 3.67, meaning it holds 3.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 6.12, indicating elevated leverage, while an interest coverage ratio of 31.72 demonstrates strong ability to service its debt obligations.
| Current Ratio | 3.67 |
| Quick Ratio | 0.99 |
| Debt / Equity | 6.12 |
| Debt / EBITDA | N/A |
| Interest Coverage | 31.72 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 105.00 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, Zydus Wellness Limited has paid 254.00M in income taxes, reflecting an effective tax rate of 7.21.
| Income Tax | 254.00M |
| Effective Tax Rate | 7.21 |
Stock Price Statistics
Zydus Wellness Limited's stock has gained approximately 41.46033% over the past 52 weeks. The 50-day moving average sits at 516.11, while the 200-day moving average is 460.35.
| Beta (5Y) | N/A |
| 52-Week Price Change | 41.46033% |
| 50-Day Moving Average | 516.11 |
| 200-Day Moving Average | 460.35 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Zydus Wellness Limited generated 27.10B in revenue and converted that into 3.27B in net income, yielding earnings per share of 10.28. EBITDA reached 3.46B, while operating income came in at 3.46B.
| Revenue | 27.10B |
| Gross Profit | 14.17B |
| Operating Income | 3.46B |
| Pretax Income | 3.53B |
| Net Income | 3.27B |
| EBITDA | 3.46B |
| EBIT | 3.46B |
| Earnings Per Share (EPS) | 10.28 |
Margins
Zydus Wellness Limited operates with a gross margin of 52.30, reflecting its pricing power and cost economics. The operating margin of 12.76 and net profit margin of 12.07 provide insight into operational efficiency.
| Gross Margin | 52.30 |
| Operating Margin | 12.76 |
| Pretax Margin | 13.01 |
| Profit Margin | 12.07 |
| EBITDA Margin | 12.76 |
Stock Splits
Zydus Wellness Limited's most recent stock split took place on September 18, 2025 with a 1:5 split ratio.
| Last Split Date | 9/18/2025 |
| Split Ratio | 1:5 |
Scores
Zydus Wellness Limited posts an Altman Z-Score of 30.43, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 30.43 |